货号:A660516
同义名:
Wnt Agonist II;SKL2001(GMP)
SKL2001是一种 Wnt/β-catenin 信号通路的激动剂,通过干扰 Axin 和 β-catenin 的相互作用,稳定 β-catenin 并具有抗肿瘤活性。
规格 | 价格 | 会员价 | 库存 | 数量 | |||
---|---|---|---|---|---|---|---|
{[ item.pr_size ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]} {[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price) ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price) ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price) ]} | {[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate) ]} | 现货 | 1周 咨询 | - + |
快速发货 顺丰冷链运输,1-2 天到达
品质保证
技术支持
免费溶解
描述 | SKL2001 acts as an agonist for the Wnt/β-catenin signaling pathway and exhibits anti-cancer properties. It achieves stabilization of β-catenin within cells by disrupting the interaction between Axin and β-catenin. Additionally, SKL2001 upregulates Axin2 expression, a downstream component of the Wnt/β-catenin pathway, while not affecting NF-κB, p53 reporter activities, or GSK-3β activity. It promotes osteoblast differentiation at concentrations of 20 and 40 μM and inhibits preadipocyte differentiation at 5, 10, and 30 μM, through the activation of the Wnt/β-catenin pathway. At these same concentrations, SKL2001 also maintains the stability of intracellular β-catenin in 3T3-L1 cells[1]. At a concentration of 40 μM, SKL2001 markedly suppresses the proliferation of HCT116 spheroids without inducing cytotoxic effects, and this suppression can be reversed. Additionally, SKL2001 induces cell cycle arrest in HCT116 spheroids. Furthermore, at the same concentration, SKL2001 promotes the formation of round-shaped spheroids and the expression of E-cadherin[2]. |
Dose | Rat: 25 mg/kg[2] (I.p.) |
Administration | i.p. |
计算器 | ||||
存储液制备 | ![]() |
1mg | 5mg | 10mg |
1 mM 5 mM 10 mM |
3.49mL 0.70mL 0.35mL |
17.47mL 3.49mL 1.75mL |
34.93mL 6.99mL 3.49mL |
CAS号 | 909089-13-0 |
分子式 | C14H14N4O3 |
分子量 | 286.286 |
别名 | Wnt Agonist II;SKL2001(GMP) |
运输 | 蓝冰 |
存储条件 |
In solvent -20°C:3-6个月-80°C:12个月 Pure form Sealed in dry,2-8°C |
溶解方案 |
DMSO: 100 mg/mL(349.3 mM),注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO 以下溶解方案都请先按照体外实验的方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议现用现配,当天使用; 以下溶剂前显示的百分比是指该溶剂在终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶
|
动物实验配方 |
2% DMSO+40% PEG 300+2% Tween 80+water 7 mg/mL |